Address
China Development Industrial Bank
Taipei,
Taiwan
Phone
Website
Recent investment activity
KANDO id: 39555
Company type
Private development financial institution in Taiwan.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 23 of 23| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
AuthenTec Inc | AuthenTec is a leading provider of mobile and network security. | N/A | |||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Dynavax Technologies Corp | N/A | ||||
|
|
IC Media Corp | Electronics/Chips & Semiconductors company based in Santa Clara, California. | N/A | |||
|
|
Icagen Inc | Biopharmaceutical company developing small molecule therapeutics that target ion channels for treatment of a variety of diseases. | N/A | |||
|
|
Inapac Technology Inc | N/A | ||||
|
|
InnoPath Software Inc | N/A | ||||
|
|
Inovise Medical Inc | Diagnostic medical technology company that is shaping cardiac care worldwide. | N/A | |||
|
|
Iomai Corp | Biopharmaceutical company focused on discovering and developing vaccines and immune system stimulants. | Series C | |||
|
|
Light Sciences Oncology Inc | Drug-device cancer therapy | Series A | |||
|
|
MontaVista Software LLC | N/A | ||||
|
|
Nereus Pharmaceuticals Inc | Series B | ||||
|
|
Optimer Pharmaceuticals Inc | Global biopharmaceutical company. | N/A | |||
|
|
PTC Therapeutics Inc | Biopharmaceutical company. | N/A | |||
|
R2 Technology Inc | N/A | ||||
|
|
WebEx Communications Inc | Web conferencing company. | N/A | |||
|
|
Wintegra | Provider of access processing semiconductors enabling the delivery of new services for the evolving communications network infrastructure. | N/A | |||
|
|
Yazam Inc | N/A | ||||
|
|
Zeevo Inc | N/A | ||||
|
|
ZettaCom Inc | N/A | ||||
|
|
Acorda Therapeutics Inc | A biotechnology company whose mission is to develop and market therapeutic products for spinal cord injury and other central nervous system disorders. | N/A | |||
|
Aderis Pharmaceuticals Inc | Novel small molecule, receptor-specific therapeutics company for the treatment of central nervous system, cardiovascular and renal diseases. | Series D Initial investment | |||
|
Entropic Communications Inc | Fabless semiconductor company. | Series B Initial investment | |||
|
Nanosys Inc | Nanotechnology-enabled systems | N/A |